President of Industry Standard Research Andrew Schafer talks with Life Science Leader about the state of the CRO market, and why it has seen continued growth even as the S&P 500 fell by 6% in 2018.
Most of this growth has and will continue to come from three areas, an increase in the number of biologic products in development, the overall healthy appetite for venture capital investment into the life science industry, and an increasing outsourcing rate.
Read more at Life Science Leader, and check out our 2019 CRO Market Size Projections: 2018-2023 to get the full breakdown of the forces affecting growth in the CRO space.
